Lexicon Pharmaceuticals
LXRX
LXRX
119 hedge funds and large institutions have $418M invested in Lexicon Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 30 increasing their positions, 31 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
3% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 31
4.86% less ownership
Funds ownership: 75.03% → 70.17% (-4.9%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
119
Holding in Top 10
1
Calls
$14.3M
Puts
$1.26M
Top Buyers
| 1 | +$27.9M | |
| 2 | +$8.5M | |
| 3 | +$5.35M | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$3.37M |
| 5 |
BlackRock
New York
|
+$1.65M |
Top Sellers
| 1 | -$54.6M | |
| 2 | -$7.09M | |
| 3 | -$3.82M | |
| 4 |
Millennium Management
New York
|
-$2.64M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.56M |